Fortrea Holdings, Inc. (FTRE)
20.00
+0.60
(+3.09%)
USD |
NASDAQ |
Oct 02, 16:00
20.00
0.00 (0.00%)
After-Hours: 20:00
Fortrea Holdings Shareholders Equity (Quarterly) : 524.20M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 524.20M |
| March 31, 2026 | 525.90M |
| December 31, 2025 | 563.50M |
| September 30, 2025 | 580.80M |
| June 30, 2025 | 589.20M |
| March 31, 2025 | 858.80M |
| December 31, 2024 | 1.362B |
| September 30, 2024 | 1.514B |
| Date | Value |
|---|---|
| June 30, 2024 | 1.461B |
| March 31, 2024 | 1.592B |
| December 31, 2023 | 1.714B |
| September 30, 2023 | 1.694B |
| June 30, 2023 | 1.751B |
| March 31, 2023 | 3.406B |
| December 31, 2022 | 3.343B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Charles River Laboratories International, Inc. | 2.840B |
| IQVIA Holdings, Inc. | 6.171B |
| Medpace Holdings, Inc. | 433.86M |
| Champions Oncology, Inc. | 3.893M |
| Avantor, Inc. | 5.630B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.715B |
| Total Liabilities (Quarterly) | 2.191B |
| Debt to Equity Ratio | 2.132 |
| Current Ratio | 0.9584 |
| Net Debt Paydown Yield | 2.04% |